Woodline Partners’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,791,553
| Closed | -$5.55M | – | 611 |
|
|
2023
Q4 | $5.55M | Buy |
1,791,553
+700,813
| +64% | +$2.17M | 0.06% | 304 |
|
|
2023
Q3 | $6.7M | Buy |
1,090,740
+357,005
| +49% | +$2.19M | 0.08% | 273 |
|
|
2023
Q2 | $4.59M | Buy |
733,735
+557,847
| +317% | +$3.49M | 0.05% | 302 |
|
|
2023
Q1 | $839K | Sell |
175,888
-832,799
| -83% | -$3.97M | 0.01% | 486 |
|
|
2022
Q4 | $8.78M | Buy |
1,008,687
+109,380
| +12% | +$952K | 0.12% | 234 |
|
|
2022
Q3 | $10.7M | Buy |
899,307
+429,424
| +91% | +$5.11M | 0.15% | 193 |
|
|
2022
Q2 | $6.7M | Sell |
469,883
-248,210
| -35% | -$3.54M | 0.1% | 218 |
|
|
2022
Q1 | $15M | Buy |
718,093
+419,483
| +140% | +$8.73M | 0.24% | 124 |
|
|
2021
Q4 | $6.9M | Sell |
298,610
-108,755
| -27% | -$2.51M | 0.1% | 246 |
|
|
2021
Q3 | $12.1M | Buy |
407,365
+168,284
| +70% | +$5.01M | 0.2% | 140 |
|
|
2021
Q2 | $8.17M | Buy |
239,081
+15,391
| +7% | +$526K | 0.15% | 158 |
|
|
2021
Q1 | $7.36M | Sell |
223,690
-1,131
| -0.5% | -$37.2K | 0.16% | 158 |
|
|
2020
Q4 | $13.8M | Buy |
224,821
+17,400
| +8% | +$1.07M | 0.37% | 85 |
|
|
2020
Q3 | $7.36M | Buy |
+207,421
| New | +$7.36M | 0.24% | 105 |
|